Spastic Quadriplegia Resulting From a Pathogenic Variant in the SPAST Gene: A First Report
Case Reports in Neurological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crnm/2632593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, online erschienen am 29.04.2026. Verfasst von Eirini Kostopoulou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University General Hospital of Patras, Patras, 26500, Greece, pgnp.gr. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The SPAST gene encodes spastin, a microtubule‐severing protein. Pathogenic variants in this gene are commonly associated with autosomal dominant Spastic paraplegia type 4 ( SPG4 ), a neurodegenerative disorder presenting with progressive lower limb spasticity. Severe phenotypes involving more extensive neurological impairment are rare. Case Presentation We report the first known case of an adolescent with a rare pathogenic SPAST variant (NM_014946.4: c.1507C > T; NP_055761.2: p. [Arg503Trp]) presenting with spastic quadriplegia. Additional features included severe intellectual disability, absent speech, dysphagia, and epilepsy, manifestations infrequently reported in association with SPAST mutations. He was born prematurely at 32 weeks of gestation after a complicated antenatal period due to the development of preeclampsia at 23 weeks and gestational diabetes mellitus at 26 weeks.
Discussion
The patient’s clinical presentation represents one of the most severe phenotypes described in the literature for SPAST ‐related disorders. The identification of a genetic cause provided a more satisfactory and specific diagnosis than the previously presumed etiology of perinatal asphyxia. This case broadens the phenotypic spectrum of SPAST ‐related disease and highlights the role of genetic testing in the diagnostic workup of complex neurological conditions.
Conclusion
We report the first case of a pathogenic variant in the SPAST gene and quadriplegia and one of the most severe clinical phenotypes described in the literature in association with variants in this gene. This report underscores the importance of considering SPAST mutations in patients with atypical or severe neurodevelopmental presentations. Genetic diagnosis enables more accurate prognosis, individualized medical care, and appropriate genetic counseling for families.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, University General Hospital of Patras, Patras, 26500, Greece, pgnp.gr.
- Medical School of Patras, University of Patras, Patras, 26504, Greece, upatras.gr.
- Internal Medicine Department, University General Hospital of Patras, Patras, 26500, Greece, pgnp.gr.
- 3billion Inc., Seoul, South Korea.
ORCID-Profile: Eirini Kostopoulou, Maria Lagadinou, Rin Khang, Gabriel Dimitriou
Zitieren
APA
Kostopoulou, E., Lagadinou, M., Karatza, A., Sinopidis, X., Khang, R., & Dimitriou, G. (2026). Spastic Quadriplegia Resulting From a Pathogenic Variant in the SPAST Gene: A First Report. Case Reports in Neurological Medicine, 2026(1). https://doi.org/10.1155/crnm/2632593
Vancouver
Kostopoulou E, Lagadinou M, Karatza A, Sinopidis X, Khang R, Dimitriou G. Spastic Quadriplegia Resulting From a Pathogenic Variant in the SPAST Gene: A First Report. Case Reports in Neurological Medicine. 2026;2026(1). doi:10.1155/crnm/2632593
BibTeX
@article{Kostopoulou2026,
author = {Kostopoulou, Eirini and Lagadinou, Maria and Karatza, Ageliki and Sinopidis, Xenophon and Khang, Rin and Dimitriou, Gabriel},
title = {Spastic Quadriplegia Resulting From a Pathogenic Variant in the SPAST Gene: A First Report},
journal = {Case Reports in Neurological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crnm/2632593}
}
EUVIMED